| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 58.53B | 64.54B | 52.98B | 43.66B | 42.66B | 39.70B |
| Gross Profit | 11.45B | 11.59B | 10.70B | 8.87B | 8.65B | 7.95B |
| EBITDA | 5.57B | 3.67B | 5.02B | 1.98B | 1.94B | 1.59B |
| Net Income | 4.22B | 1.83B | 3.72B | 1.16B | 1.02B | 781.00M |
Balance Sheet | ||||||
| Total Assets | 55.51B | 59.51B | 58.01B | 49.65B | 44.52B | 45.51B |
| Cash, Cash Equivalents and Short-Term Investments | 10.27B | 9.91B | 8.83B | 8.64B | 9.59B | 9.08B |
| Total Debt | 7.81B | 4.59B | 7.64B | 4.26B | 3.60B | 4.45B |
| Total Liabilities | 26.74B | 27.68B | 28.65B | 23.95B | 20.96B | 22.89B |
| Stockholders Equity | 28.76B | 31.82B | 29.36B | 25.68B | 23.55B | 22.62B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.78B | -1.04B | -1.26B | 1.22B | -753.00M |
| Operating Cash Flow | 0.00 | 5.09B | -798.00M | -1.01B | 1.59B | -510.00M |
| Investing Cash Flow | 0.00 | 394.00M | 245.00M | 353.00M | -37.00M | 951.00M |
| Financing Cash Flow | 0.00 | -4.34B | 1.12B | -498.00M | -1.67B | -628.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥223.86B | 6.85 | 17.09% | 2.94% | 20.29% | 94.13% | |
72 Outperform | ¥57.62B | 17.28 | ― | 4.12% | 6.27% | 31.76% | |
67 Neutral | ¥20.36B | 11.34 | ― | 3.83% | 21.81% | -49.75% | |
64 Neutral | ¥41.92B | 12.72 | ― | 5.16% | 1.23% | -22.74% | |
62 Neutral | ¥12.69B | 8.16 | ― | 4.62% | -0.44% | -13.10% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | ¥46.67B | 40.14 | 1.55% | 1.34% | -14.56% | 181.24% |